{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/IMVT/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-09T09:52:46.118Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9106,"canonical_name":"Immunovant, Inc.","cik":"0001764013","uei":null,"lei":null,"duns":null,"ticker":"IMVT"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":42},"count":42,"timeline":[{"ts":"2026-07-22","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — Immunovant, Inc. — 2026-07-22","url_slug":"/sec/cik-0001764013/def-14a/0001764013-26-000092","accession_number":"0001764013-26-000092","importance":40},{"ts":"2026-07-22","kind":"sec.filing","form_type":"ARS","title":"ARS — Immunovant, Inc. — 2026-07-22","url_slug":"/sec/cik-0001764013/ars/0001764013-26-000094","accession_number":"0001764013-26-000094","importance":30},{"ts":"2026-07-22","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Immunovant, Inc. — 2026-07-22","url_slug":"/sec/cik-0001764013/defa14a/0001764013-26-000093","accession_number":"0001764013-26-000093","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"4","title":"4 — Immunovant, Inc. — 2026-07-06","url_slug":"/sec/cik-0001764013/4/0001764013-26-000077","accession_number":"0001764013-26-000077","importance":30},{"ts":"2026-07-02","kind":"sec.insider.s","reporter":"Venker Eric","title":"Chief Executive Officer","shares":3092,"price_per_share":38.48,"usd_value":118980,"security_title":"Common Stock","importance":35.11898016},{"ts":"2026-07-01","kind":"sec.insider.d","reporter":"Venker Eric","title":"Chief Executive Officer","shares":86629,"price_per_share":38.14,"usd_value":3304030,"security_title":"Common Stock","importance":18.30403006},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"Venker Eric","title":"Chief Executive Officer","shares":92188,"price_per_share":14.46,"usd_value":1333038,"security_title":"Common Stock","importance":16.33303848},{"ts":"2026-06-26","kind":"sec.form144","reporter":"JAY S STOUT","title":"Officer","shares":40000,"usd_value":1532196,"security_title":"Common","approx_sale_date":"2026-06-26","accession_number":"0001950047-26-006543","importance":40.3064392},{"ts":"2026-06-26","kind":"sec.form144","reporter":"CHRIS ADAIR VAN TUYL","title":"Officer, Director","shares":17824,"usd_value":682800,"security_title":"Common","approx_sale_date":"2026-06-26","accession_number":"0001950047-26-006532","importance":40.136560002},{"ts":"2026-06-26","kind":"sec.form144","reporter":"MELANIE GLORIA","title":"Officer","shares":17714,"usd_value":678552,"security_title":"Common","approx_sale_date":"2026-06-26","accession_number":"0001950047-26-006531","importance":40.135710496},{"ts":"2026-06-26","kind":"sec.form144","reporter":"TIAGO GIRAO","title":"Officer","shares":10000,"usd_value":384640,"security_title":"Common","approx_sale_date":"2026-06-26","accession_number":"0001950047-26-006530","importance":40.076928},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Stout Jay S","title":"Chief Technology Officer","shares":33277,"price_per_share":38.18,"usd_value":1270516,"security_title":"Common Stock","importance":36.27051586},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Van Tuyl Christopher","title":"Chief Legal Officer","shares":14982,"price_per_share":38.19,"usd_value":572163,"security_title":"Common Stock","importance":35.57216258},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Gloria Melanie","title":"Chief Operating Officer","shares":14748,"price_per_share":38.18,"usd_value":563079,"security_title":"Common Stock","importance":35.56307864},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Girao Tiago","title":"Chief Financial Officer","shares":10000,"price_per_share":38.46,"usd_value":384600,"security_title":"Common Stock","importance":35.3846},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Stout Jay S","title":"Chief Technology Officer","shares":6723,"price_per_share":38.94,"usd_value":261794,"security_title":"Common Stock","importance":35.26179362},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Gloria Melanie","title":"Chief Operating Officer","shares":2966,"price_per_share":38.95,"usd_value":115526,"security_title":"Common Stock","importance":35.1155257},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Van Tuyl Christopher","title":"Chief Legal Officer","shares":2842,"price_per_share":38.96,"usd_value":110724,"security_title":"Common Stock","importance":35.11072432},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Pande Atul","title":null,"shares":1500,"price_per_share":38.01,"usd_value":57015,"security_title":"Common Stock","importance":35.057015},{"ts":"2026-06-26","kind":"sec.filing","form_type":"144","title":"144 — Girao Tiago — 2026-06-26","url_slug":"/sec/cik-0001618670/144/0001950047-26-006530","accession_number":"0001950047-26-006530","importance":30},{"ts":"2026-06-26","kind":"sec.filing","form_type":"144","title":"144 — Immunovant, Inc. — 2026-06-26","url_slug":"/sec/cik-0001764013/144/0001950047-26-006531","accession_number":"0001950047-26-006531","importance":30},{"ts":"2026-06-26","kind":"sec.filing","form_type":"144","title":"144 — Immunovant, Inc. — 2026-06-26","url_slug":"/sec/cik-0001764013/144/0001950047-26-006532","accession_number":"0001950047-26-006532","importance":30},{"ts":"2026-06-26","kind":"sec.filing","form_type":"4","title":"4 — Girao Tiago — 2026-06-26","url_slug":"/sec/cik-0001618670/4/0001764013-26-000072","accession_number":"0001764013-26-000072","importance":30},{"ts":"2026-06-26","kind":"sec.filing","form_type":"4","title":"4 — Immunovant, Inc. — 2026-06-26","url_slug":"/sec/cik-0001764013/4/0001764013-26-000073","accession_number":"0001764013-26-000073","importance":30},{"ts":"2026-06-26","kind":"sec.filing","form_type":"4","title":"4 — Immunovant, Inc. — 2026-06-26","url_slug":"/sec/cik-0001764013/4/0001764013-26-000075","accession_number":"0001764013-26-000075","importance":30},{"ts":"2026-06-26","kind":"sec.insider.33277","reporter":"Stout Jay S","title":"Chief Technology Officer","shares":33277,"price_per_share":38.18,"usd_value":1270516,"security_title":"Common Stock","importance":16.27051586},{"ts":"2026-06-26","kind":"sec.insider.14748","reporter":"Gloria Melanie","title":"Chief Operating Officer","shares":14748,"price_per_share":38.18,"usd_value":563079,"security_title":"Common Stock","importance":15.56307864},{"ts":"2026-06-26","kind":"sec.insider.m","reporter":"Van Tuyl Christopher","title":"Chief Legal Officer","shares":17824,"price_per_share":15.2,"usd_value":270925,"security_title":"Common Stock","importance":15.2709248},{"ts":"2026-06-26","kind":"sec.insider.6723","reporter":"Stout Jay S","title":"Chief Technology Officer","shares":6723,"price_per_share":38.94,"usd_value":261794,"security_title":"Common Stock","importance":15.26179362},{"ts":"2026-06-26","kind":"sec.insider.m","reporter":"Girao Tiago","title":"Chief Financial Officer","shares":10000,"price_per_share":15.9,"usd_value":159000,"security_title":"Common Stock","importance":15.159},{"ts":"2026-06-26","kind":"sec.insider.2966","reporter":"Gloria Melanie","title":"Chief Operating Officer","shares":2966,"price_per_share":38.95,"usd_value":115526,"security_title":"Common Stock","importance":15.1155257},{"ts":"2026-06-26","kind":"sec.insider.m","reporter":"Pande Atul","title":null,"shares":1500,"price_per_share":8.43,"usd_value":12645,"security_title":"Common Stock","importance":15.012645},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — Immunovant, Inc. — 2026-06-22","url_slug":"/sec/cik-0001764013/4/0001779707-26-000006","accession_number":"0001779707-26-000006","importance":30},{"ts":"2026-06-18","kind":"sec.insider.s","reporter":"Van Tuyl Christopher","title":"Chief Legal Officer","shares":2634,"price_per_share":35.39,"usd_value":93217,"security_title":"Common Stock","importance":35.09321726},{"ts":"2026-06-15","kind":"sec.form144","reporter":"Atul Pande","title":"Director","shares":6000,"usd_value":201720,"security_title":"Common","approx_sale_date":"2026-06-15","accession_number":"0001950047-26-006090","importance":40.040344},{"ts":"2026-06-15","kind":"sec.insider.s","reporter":"Pande Atul","title":null,"shares":1500,"price_per_share":34.02,"usd_value":51030,"security_title":"Common Stock","importance":35.05103},{"ts":"2026-06-15","kind":"sec.insider.m","reporter":"Pande Atul","title":null,"shares":1500,"price_per_share":8.43,"usd_value":12645,"security_title":"Common Stock","importance":15.012645},{"ts":"2026-05-20","kind":"sec.filing","form_type":"10-K","title":"10-K — Immunovant, Inc. — 2026-05-20","url_slug":"/sec/cik-0001764013/10-k/0001764013-26-000064","accession_number":"0001764013-26-000064","importance":55},{"ts":"2026-05-20","kind":"sec.form144","reporter":"Atul Pande","title":"Director","shares":6000,"usd_value":157740,"security_title":"Common","approx_sale_date":"2026-05-20","accession_number":"0001950047-26-004841","importance":40.031548},{"ts":"2026-05-20","kind":"sec.insider.s","reporter":"Pande Atul","title":null,"shares":6000,"price_per_share":32,"usd_value":192000,"security_title":"Common Stock","importance":35.192},{"ts":"2026-05-20","kind":"sec.filing","form_type":"8-K","title":"8-K — Immunovant, Inc. — 2026-05-20","url_slug":"/sec/cik-0001764013/8-k/0001764013-26-000062","accession_number":"0001764013-26-000062","importance":35},{"ts":"2026-05-20","kind":"sec.insider.m","reporter":"Pande Atul","title":null,"shares":6000,"price_per_share":8.43,"usd_value":50580,"security_title":"Common Stock","importance":15.05058}]}